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Synopsis
Cyclophilin 40 (Cyp40) comprises an N-terminal cyclophilin domain with peptidyl-prolyl isomerase (PPIase) activity and
a C-terminal tetratricopeptide repeat (TPR) domain that binds to the C-terminal –EEVD sequence common to both
heat shock protein 70 (Hsp70) and Hsp90. We show in the present study that binding of peptides containing the
MEEVD motif reduces the PPIase activity by ∼30%. CD and fluorescence assays show that the TPR domain is less
stable than the cyclophilin domain and is stabilized by peptide binding. Isothermal titration calorimetry (ITC) shows
that the affinity for the –MEEVD peptide is temperature sensitive in the physiological temperature range. Results from
these biophysical studies fit with the MD simulations of the apo and holo (peptide-bound) structures which show a
significant reduction in root mean square (RMS) fluctuation in both TPR and cyclophilin domains when –MEEVD is
bound. The MD simulations of the apo-protein also highlight strong anti-correlated motions between residues around
the PPIase-active site and a band of residues running across four of the seven helices in the TPR domain. Peptide
binding leads to a distortion in the shape of the active site and a significant reduction in these strongly anti-correlated
motions, providing an explanation for the allosteric effect of ligand binding and loss of PPIase activity. Together the
experimental and MD results suggest that on heat shock, dissociation of Cyp40 from complexes mediated by the
TPR domain leads to an increased pool of free Cyp40 capable of acting as an isomerase/chaperone in conditions of
cellular stress.
Key words: allostery, heat-shock protein 90, immunophilin, molecular dynamics, peptidyl-prolyl isomerase,
tetratricopeptide (TPR) domain.
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INTRODUCTION
Immunophilins are peptidyl-prolyl isomerases (PPIase) that in-
clude the structurally unrelated families of cyclophilins and FK-
BPs (FK506-binding proteins). Cyclophilin A (CypA), the ar-
chetypal cyclophilin, has a single PPIase domain of 165 amino
acids and catalyses the inter-conversion between cis and trans
forms of the peptidyl-prolyl bond (EC 5.2.1.8). There are 20 cyc-
lophilin paralogues in the human genome which are found in
diverse cellular compartments and form components of multiple
cell signalling pathways and steroid receptor complexes [1–3].
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Abbreviations: Cyp40, cyclophilin 40; CsA, cyclosporin A; CypA, cyclophilin A; FKBP, FK506 binding protein; Hsp, heat shock protein; ITC, isothermal titration calorimetry; PPIase,
peptidyl-prolyl isomerase; RMS, root mean square; TDF, thermal denaturation fluorescence; TPR, tetratricopeptide repeat; wt, wild-type.
1 To whom correspondence should be addressed (email m.walkinshaw@ed.ac.uk).
The single domain prototypic cyclophilins show PPIase activity
with kcat/Km values ranging from 5.5 × 105 to 1.4 × 107 M− 1 s− 1
[1]. A likely consequence of this enzymatic activity is their abil-
ity to catalyse the rate of protein folding in the cell. In various
in vitro assays, protein folding speeds up from seconds to mil-
liseconds [4]. NMR relaxation experiments have been used to
show that intrinsic CypA motions occur with frequencies that
are similar to the catalytic turnover of peptide substrates meas-
ured at between 12000 and 13000 s− 1 [5,6]. Cyclophilins are
known to associate with a wide variety of protein partners and are
present in large protein complexes as co-chaperones [7]. Whether
the presence of a PPIase domain confers molecular recognition,
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Figure 1 Cyp40 architecture
Cyp40 has a single N-terminal cyclophilin domain (green) connected by a 30-amino acid linker to a TPR domain (blue)
composed of three tandem TPRs. Phe133 forms the base of the active site. Cyp40 (1IHG.pdb) modelled with CsA (magenta),
based on an alignment of CypA in complex with CsA (1CWA.pdb) and MEEVD peptide (orange), based on an alignment of
CHIP in complex with peptide (2C2L.pdb).
isomerase or chaperone activity is not fully understood but is
likely to be dependent on both the protein partner and the nature
of the additional domains present in the multi-domain cyclophil-
ins. A ligand binding to an accessory domain has been shown to
influence PPIase activity in a number of multi-domain PPIases.
FKBP38 contains a PPIase domain and a C-terminal TPR domain
that binds heat shock protein 90 (Hsp90). The PPIase activity of
FKBP38 is stimulated by the binding of Ca2 + /calmodulin to the
unusual N-terminal extension of the PPIase domain. In contrast,
PPIase activity is reduced when Hsp90 binds to the TPR domain
[8]. Cyclophilin 33 (Cyp33) contains an RNA-binding domain;
PPIase activity is increased by mRNA binding [9]. However, the
PPIase activity of AtCyp59 (Arabidopsis thaliana cyclophilin 59)
is inhibited by RNA binding [10]. Allosteric inter-domain com-
munication influences the PPIase activity of Pin1 (peptidyl-prolyl
cis-trans isomerase NIMA-interacting 1) [11,12].
Another near-universal property of the cyclophilins is the tight
binding to, and inhibition by, the immunosuppressant peptide
drug cyclosporin A (CsA). This cyclic undecapeptide binds in
the active site of most cyclophilin paralogues with Kd values
ranging from very low nanomolar to micromolar [13].
In the present paper, we investigate the allosteric regulation
of the enzyme activity of cyclophilin 40 (known as Cyp40
and more confusingly as PPID). Cyp40 has high catalytic ef-
ficiency (kcat/Km = 1.3 × 107 M−1 s−1), similar to that of CypA
(kcat/Km = 1.4 × 107 M− 1 s− 1). The affinity for CsA is 61 nM,
within the range of the prototypic cyclophilins which have Kd
between 10 and 100 nM [13]. Cyp40, in common with seven
of the FKBPs, has a C-terminal TPR domain made up of three
helix-turn-helix tetratricopeptide repeat (TPR) motifs. The single
N-terminal cyclophilin domain of Cyp40 is connected by a 30
amino acid linker to the TPR domain (Figure 1) [14]. Cyp40 is
frequently grouped with the well characterized ‘large immuno-
philins’ FKBP51 and 52, due to their similar size and associ-
ated biological roles as part of steroid receptors. The TPR do-
mains of FKBP51 and FKBP52 share 25 % and 28 % identity
respectively with the TPR domain of Cyp40. The immunophilin
TPR proteins form a sub-set of a bigger group of proteins con-
taining a TPR domain which bind competitively to Hsp90 or
Hsp70 and act as co-chaperones [15]. Low sequence identities
between TPR domains is characteristic of the fold and masks
good conservation between specific residues in the immunophilin
co-chaperone TPRs that make key interactions with Hsps (Sup-
plementary Figure S1). There is a 75-fold increase in Cyp40
mRNA levels on heat shock but also increased levels of degrada-
tion leading to similar protein levels. One could imply from this
that Cyp40 has an important cellular role in times of heat stress
[16].
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Binding of the TPR domain to the Hsp is via their C-terminal
amino acids; Hsp90 has the terminal sequence MEEVD-COOH
and Hsp70 has the C-terminal sequence IEEVD-COOH [17].
Cyp40 has a preference for Hsp90 and has been found asso-
ciated with Hsp90 as a binary complex and as a component
of the mature unactivated AR (androgen receptor), ER (estro-
gen receptor), PR (progesterone receptor) and steroid receptor
complex. It also acts as a facilitator of membrane transfer
for clostridial ADP-ribosyltransferases [18–22]. Bovine Cyp40
(bCyp40) has been crystallized as an apo protein with the
TPR domain in two conformations. In 1IHG.pdb the TPR do-
main adopts the typical TPR fold and 1IIG.pdb where two
of the TPR helices have straightened out to form one exten-
ded helix [14]. To date, X-ray structures of eight distinct TPR
domains have been solved from five human proteins bound
to Hsp90 or Hsp70 C-terminal peptides [RPAP3:4CGV.pdb-
TPR1(SRMEEVD) and 4CGW.pdb-TPR2(SRMEEVD); CHIP:
-4KBQ.pdb-TPR(Hsp70 C-terminal and lid fragments); AIP:4AI
-F.pdb-TPR(SRMEEVD); HOP:1ELW.pdb-TPR1(GPTIEEVD),
3ESK.pdb-TPR2A(GPTIEEVD) and 1ELR.pdb-TPR2B(ME
-EVD); FKBP52:1QZ2.pdb-TPR(MEEVD)]. All show a
peptide lying in a groove between helix 1 and helix 5 and the
C-terminus bound in a ‘carboxy clamp’ pocket (Figure 1). This
proposed binding mode is also supported by a study of site point
mutations of Cyp40 which identified key interacting residues
[23].
We show in the present paper that binding of ligand to the
TPR domain has an allosteric effect on the PPIase activity. The
classic Monod – Wyman–Changeux model of allostery describes
a conformational switch between two well-defined low-energy
forms, but there is growing evidence to show that allostery may
be understood in terms of an alteration of protein flexibility or
reshaping of the energy landscape upon effector binding [24].
Biophysical measurements using fluorescence, CD spectroscopy
and thermal denaturation spectroscopy have all been used to mon-
itor the melting behaviour of Cyp40 in the presence and absence
of peptide ligand. These measurements are combined with MD
and enzymatic results to suggest that the observed allosteric beha-
viour is through regulation of protein flexibility and, in particular,
by changes in correlated motions which can be adjusted by ligand
binding.
EXPERIMENTAL
Protein production
Cyp40 (pDEST14-6H-TEV-hCyp40) and CypA were overex-
pressed in E.coli [BL21 starTM (DE3), Life Technologies] es-
sentially as described for CypA by Wear et al. [25]. In summary,
proteins were purified to homogeneity by ion-metal affinity chro-
matography (1 ml, HiTrap IMAC,ff; GE Healthcare Life Sci-
ences) followed by gel filtration (Superdex 200 10/300 GL). Pur-
ity was assessed to be greater than 95 % by SDS/PAGE. The
hydrodynamic properties of Cyp40 and CypA were assessed by
dynamic light scattering; they showed no measurable aggrega-
tion and were consistent with those of monomeric protein when
compared with X-ray crystallographic co-ordinates (Zetasizer,
Malvern Instruments; Hydropro10) [26].
Peptidyl-prolyl isomerase activity
PPIase activity of Cyp40 (10 nM) was compared for the unligan-
ded (apo) form and in the presence of 250 μM XXXXXMEEVD
peptide (holo) at 10 ◦C with the substrate Suc-A-A-P-F-p-
NA (Sigma); 50 mM Hepes, pH 8; 100 mM sodium chlor-
ide; 1 mM DTT determined as previously described [27]. us-
ing the method of Kofron (Jasco V-550 UV/vis spectrometer)
[28].
CD spectroscopy
The far UV CD spectrum of 0.75 μM Cyp40 was recorded at
20 nm min− 1; data pitch 0.1 nm; response time 1 s between
185 and 285 nm in a 0.1 cm path-length quartz cuvette between
10 ◦C and 60 ◦C at 10 ◦C intervals (JASCO-810 spectrometer).
The protein was exchanged into 10 mM sodium phosphate, pH 8;
150 mM sodium fluoride prior to analysis (HiTrap desalt column,
GE). Spectra were corrected by subtracting a buffer baseline re-
corded at each temperature, spectra were recorded in triplicate.
Secondary structure was estimated using the Dichroweb CD sec-
ondary structure analysis server using the methods CONTIN,
SELCON3 and CDSSTR and data set SP175; mean results are
presented with S.E.M [29–34].
Intrinsic tryptophan fluorescence
Steady-state fluorescent emission was recorded for 1 μM
Cyp40 in the apo form and after the addition of 250 μM
SRMEEVD (Hsp90 peptide) between 15 ◦C and 45 ◦C at 5 ◦C in-
tervals in 50 mM Hepes, pH 8; 100 mM sodium chloride; 1 mM
DTT (Fluoromax-3 spectrometer, Horiba). Tryptophan was se-
lectively excited at 295 nm (5 nm band pass excitation and emis-
sion) and emission spectra recorded from 310 to 400 nm, 1 nm
interval; integration time 1 s; scans were repeated in triplicate,
mean spectra are presented. Protein scans were blanked by sub-
tracting a spectrum of a similar solution without protein at each
temperature.
Thermal denaturation fluorescence
Thermal denaturation fluorescence (TDF) melting curves were
recorded for 2 μM Cyp40 in the apo form and in the presence
of 4 μM CsA and 250 μM SRMEEVD peptide alone or to-
gether; 50 mM Hepes, pH8; 100 mM sodium chloride; 1 mM
DTT. Fluorescence intensity was measured in relative fluor-
escence units (RFU) using excitation/emission wavelengths of
485 nm/575 nm between 25 ◦C and 70 ◦C, interval 0.5 ◦C, 30 s
hold at each temperature as previously described (IQcycler5, Bio-
Rad) [35]. Data were collected in triplicated, mean thermograms
are presented.
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Figure 2 Binding MEEVD to the TPR domain of Cyp40 allosterically inhibits PPIase activity
(A) Addition of the peptide containing the Hsp C-terminal sequence, –EEVD, to Cyp40 reduced PPIase activity by 30 %.
(B) A control experiment showing that the Hsp90 peptide does not affect PPIase activity by binding competitively to the
Cyp40-active site and competing with the PPIase peptide substrate (AAPF-p-NA). Measurement was carried out using the
single domain CypA. Mean of five repeats and S.E.M. corrected for thermal turnover.
Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) experiments were carried
out to determine the affinity of Cyp40 for Hsp90 peptide over the
temperature range 10 ◦C–30 ◦C at 5 ◦C intervals (Auto-iTC200
microcalorimeter; Malvern Instruments). Cyp40 was exchanged
into the experimental buffer; 50 mM Hepes, pH 8; 100 mM so-
dium chloride; 1 mM DTT (HiTrap desalt column, GE Healthcare
Life Sciences) immediately before the experiment. SRMEEVD
(500 μM) was titrated into 7.7 μM Cyp40 in 15 × 2.5 μl ali-
quots. Data were analysed using non-linear regression in the
MicroCal ORIGIN software package assuming a 1:1 binding
model.
MD simulations
All the MD simulations were carried out in explicit solvent (wa-
ter) using NAMD 2.9 with CHARMM27 force field [36]. All
simulations were performed at constant temperature (310 K) and
pressure [1.01325 bar (1 bar = 100 kPa)] in a periodic water
box with a 20 ˚A (1 ˚A = 0.1 nm) cushion. Ions were added to
neutralize the system. Non-bonded and electrostatic forces were
evaluated each time step. No rigid bonds were used. The cut-off
distance was set to 12 ˚A to evaluate non-bonded interactions. The
Particle Ewald sum was used in calculating long-range forces in
the periodic systems, thereby minimizing the error introduced by
truncation owing to the cut-off distance. Integration time step was
set to 1 fs and structure was recorded at 1000-step (1 ps in MD).
The system was subjected to three minimization–equilibration
cycles prior to MD calculations. The first one was applied to re-
lax the water and the last two were applied to find a local energy
minimum of the whole system. All minimization cycles included
20000 energy minimization steps to relieve close intermolecular
contacts and geometric strain. Simulations were carried out for
100 ns.
RESULTS
Binding MEEVD to the TPR domain of Cyp40
allosterically influences PPIase activity
Figure 2(A) shows the PPIase activity of Cyp40 (10 nM) meas-
ured in the presence and absence of the Hsp C-terminal peptides
SRMEEVD [Hsp90 wt (wild-type)], GPTIEEVD (Hsp70 wt) and
GAAAEEVD (Hsp70 mutant). In each case, addition of the pep-
tide (250 μM) resulted in a reduction in the PPIase activity of over
30 %. In order to show that the Hsp peptides were not affecting the
assay by binding competitively to the Cyp40-active site and com-
peting with the PPIase peptide substrate peptide (AAPF-p-NA)
a control measurement was carried out using the single-domain
CypA, no reduction in activity was observed (Figure 2B). The
Hsp peptides bind to Cyp40 with Kd values of ∼5 μM (10 ◦C; ITC
data for SRMEEVD) and at the concentration used in this assay an
estimated over 98 % of Cyp40 would be bound [37]. The similar
reduction in enzyme activity for all three peptides (XXXXEEVD)
suggests that it is the binding of –EEVD to the dicarboxy
clamp region of the TPR domain that causes this inhibitory
effect.
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Figure 3 Melting of Cyp40 monitored by CD spectroscopy
(A) Changes to the CD spectra of Cyp40 from 10 ◦C to 60 ◦C indicate that melting starts between 30 ◦C (green) and 40 ◦C
(yellow). Inset (B) Analysis of the secondary structural elements, as a fraction of the total protein.
CD melting experiments
The change in secondary structure as a function of increasing
temperature was monitored using CD spectroscopy (Figure 3A).
The percentage of helix, sheet and random coil was estimated for
each temperature (Figure 3B). Changes to secondary structure are
first seen above 30 ◦C as a reduced signal in the α-helical region
of the spectrum. The cyclophilin domain of Cyp40 is largely
β-sheet and the TPR domain largely α-helical (Figure 1).
Intrinsic tryptophan fluorescence monitors
flexibility in the TPR domain
Human Cyp40 is unusual in the cyclophilin family in that there
are no tryptophan residues in the PPIase domain or linker re-
gion. There are three tryptophan residues in the TPR domain
(Figure 4A). These residues are positioned at the interfaces of
the TPRs where the motif fold back on each other and make
hydrophobic contacts. Tryptophan can therefore be considered
a good intrinsic probe of TPR dynamics as increased flexibility
or unfolding of the TPR domains would alter chemical environ-
ment [38]. Trp239 forms an interface between the hairpin loop of
helix 1 and 2 and helix 3; it makes hydrophobic contacts with
Phe234, Gln237, Lys285 and Met286 and shows little solvent ex-
posure. The crystal structure of bCyp40 has high B-factors at
the hinge between at the opposite ends of helix 2 and 3 (Glu261,
Asp262, Ala263). Movement, perpendicular to the plane of the
indole ring, at this hinge would have a direct effect on the en-
vironment of Trp239 and lead to exposure of the face of the in-
dole group to solvent and the increased possibility of rotation
about Cβ γ . Trp289 forms contacts between helices 3 and 4 and
helix 5 and Trp317 in buried in the groove formed by helices
4, 5 and 6.
Typically solvent-exposed tryptophan residues fluoresce at a
longer wavelength and have a smaller quantum yield than buried
residues [39]; thus fluorescent emission provides a time-averaged
reporter of the degree of buriedness of the indole rings. The
changes in fluorescence signal between 20 ◦C and 40 ◦C (drop in
signal and red shift from 348.3 to 351 nm) are consistent with a
steady increase in solvent exposure. At 40 ◦C, there is a marked
change and the average emission wavelength red shifts from
348.3 to 351 nm (Figures 4B and 4C).
Addition of Hsp90 peptide causes an enhancement in fluores-
cence at all temperatures and is consistent with the tryptophan
side chains being in a less solvent-exposed environment, though
the red shift observed on melting is similar to the unliganded
protein (Figures 4B and 4C).
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Figure 4 Melting of the Cyp40 TPR domain monitored by tryptophan fluorescence
(A) The three tryptophan residues of hCyp40 are located in the TPR domain at key interfaces between the three tandem
TPRs. Helices are labelled 1–6. (B) Steady state-fluorescence is strongly influenced by both temperature and ligand binding.
(C) Average emission wavelength increases with temperature and is decreased upon ligand binding.
Thermal denaturation fluorescence melting
experiments confirm that the TPR domain is mobile
at physiological temperatures
The increase in fluorescence measured in the TDF assay results
from a dye probe binding to exposed hydrophobic residues as the
protein melts and unfolds. The melting curves shown in Figure 5
show that apo Cyp40 has a Tm = 42 ◦C (mid-point melting tem-
perature) but starts to melt at 30 ◦C (solid line). Addition of Hsp90
peptide -MEEVD delays onset of melting by ∼5 ◦C, however Tm
only increases by ∼1 ◦C (dashed line). Comparison of the shapes
of these two melting curves suggests that the TPR domain and
PPIase domain do not start to melt at the same temperature. Ad-
dition of Hsp90 peptide stabilizes the TPR domain and influences
the shape of the melting curve at temperatures below those where
the cyclophilin domain is significantly destabilized. Addition of
the tight-binding CsA ligand (PPIase domain) raises the Tm by
4 ◦C upto 46 ◦C. The shape of the melting curve for addition of
the MEEVD peptide along with CsA again suggests a delay in
melting of the TPR domain but this has little effect on the final
Tm of the protein which remains at 46 ◦C.
ITC: the thermodynamics of binding of Cyp40 to
Hsp90 shows remarkable temperature sensitivity in
the physiological temperature range
ITC data measured by titrating peptide and CypA at different
temperatures shows that the there is a strong dependence on
temperature for all of the thermodynamic parameters (Figures 6A
and 6B). At 10 ◦C the Kd for Cyp40 and the MEEVD peptide
is ∼5 μM which rises to a value of ∼25 μM over which was
measured at the highest attainable temperature of 30 ◦C. The
graph of changes in H and S with temperature shows a point
of inflection between 25 ◦C and 30 ◦C suggesting, in line with
data from CD and fluorescence, this corresponds with the onset
of melting of the TPR (Figure 4). The gradient of H against
temperature also shows that Cp is not constant between 25 ◦C
and 30 ◦C. This may be explained by the likely change in water
structure as the helices of the TPR domain become more flexible
and begin to unfold.
MD simulations
MD simulations were performed on apo Cyp40 (with no peptide
ligand bound) using the X-ray structure 1IHG.pdb as the starting
model. A second MD simulation was carried out on holo-Cyp40
with the MEEVD peptide docked in the binding groove of the
TPR domain of Cyp40. The X-ray structure of the E3 ligase
CHIP (PDB code 2C2L) has a peptide with an MEEVD motif
bound to a TPR domain that is structurally homologous to the
TPR domain of Cyp40 (choice of peptide structure is described
in the Supplementary Material). A model of holo Cyp40 (bound
to the peptide MEEVD) was generated by overlaying the two
structures. The RMS fit for 90 corresponding atoms from the two
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Figure 5 TDF assay shows Hsp90 peptide stabilizes the TPR
domain
Apo Cyp40 has a Tm = 42 ◦C but starts to melt at 30 ◦C (solid line).
Addition of Hsp90 peptide –MEEVD delays onset of melting by ∼5 ◦C;
however, Tm only increases by ∼1 ◦C (dashed line). Comparison of the
shapes of these two melting curves suggests that the thermally un-
stable TPR domain is being stabilized by Hsp90 peptide at temperat-
ures below those where the cyclophilin domain becomes destabilized.
Addition of the tight binding CsA ligand (PPIase domain) raises the Tm
by 4 ◦C upto 46 ◦C (dot line). The shape of the melting curve for addition
of the MEEVD peptide along with CsA again suggests a delayed melting
of the TPR (dash/dot line).
structures is 1.1 ˚A. MD simulations were calculated for 100 ns
using this docked structure as the starting model for holo Cyp40.
Average fluctuations (mean square displacement values) for
each residue were calculated from the 100 ns simulations. The
mean square displacement values for each atom <(Ri)2> are
related to the temperature factor (Bi) by:
< (Ri )2 =
(
3/8π 2
)
Bi
The calculated B-factors determined from the holo and apo
simulations are shown in Figure 7. For the backbone atoms of the
cyclophilin domain (residues 2–186), the average holo and apo
B-values are 31.0 and 50.0 ˚A2 respectively. The C-terminal TPR
domain (residues 213–360) is found to be slightly more flexible
with B values of 32.6 and 56.2 ˚A2 for the apo and holo forms
respectively. It is clear that binding of the MEEVD peptide to the
TPR domain has a significant effect on reducing fluctuations on
both the TPR and the cyclophilin domains.
The average crystallographic B-factors measured at 100 K
were taken from X-ray structure 1IHG. For the backbone atoms
of the cyclophilin domain (residues 2–186), the average B-value
is 10.9 ˚A2 and for the TPR domain (residues 213–360), the av-
erage B-value is 12.5 ˚A2. When these values are converted into
corresponding B-values at 310 K (using a scale factor of 310/100)
the B values are 33.8 and 38.8 ˚A2 respectively. Figure 7 compares
B-factors for the X-ray structure and from MD simulations of the
apo and holo models. The simulation results are in good agree-
ment with experiment in predicting regions of low and high fluc-
tuations; however, the apo simulations overestimate the peaks.
This probably explains the large average apo B-values.
The measure of correlation between the fluctuations Ri and
Rj of ith and jth (α-carbon) atoms can be assessed by calcu-
lating the projection of the fluctuation of one atom on the other
[calculated as the magnitude of the dot product (Ri ·Rj) at
every ps) and averaged over the full 100 ns trajectory (Figure 8).
It is customary to normalize the correlations Cij of Ri and Rj
as:
Cij =
〈
Ri · Rj
〉
〈
Ri2
〉1/2〈
Rj2
〉1/2
Here, the dot in the numerator denotes the scalar product and
the angular brackets are time averages. With this normalization,
Ci j varies between –1 and + 1. This normalization removes the
effect of large fluctuations which would be dominant in the ex-
pression (Ri ·Rj),
The simulation of apo-Cyp40 shows strong anti-correlated mo-
tions between the N-terminal cyclophilin domain residues and the
C-terminal TPR domain residues The Cij values are normalized
between + 1 and –1 and there are only six regions of the molecule
that are involved in significant anti-correlated motions with Cij
values < –0.75 (Figure 8B). All of the anti-correlation peaks in-
volve interactions between the cyclophilin and TPR domains and
there are no major anti-correlated motions within either of the
two domains. The six regions are shown in Figure 8; on the TPR
domain there is region 1 (residues 354–358 on helix 7), region2
(residues 311–325 on helix 6) and region3 (residues 285–295 on
helix 4). Those residues on the cyclophilin domain that are negat-
ively coupled with the TPR regions form a band across the middle
of one face of the eight-stranded β-barrel and are composed of
three distinct regions: residues 161–177 (labelled region 4) are at
the C-terminal end of the cyclophilin domain; region 6 is the pair
of antiparallel β-strands comprising residues 70–85 and region
5 is a β-strand (residues 128–135) that lies at the centre of the
active site of the cyclophilin domain. It is significant that residues
from regions 5 and 6 play an important role in binding ligands
at the active site. Figure 9 highlights those residues that make
direct interactions with the CsA inhibitor (placed by overlaying
the CypA–CsA structure PDB code 1CWA). In particular, Phe133
is absolutely conserved in all isomerase-active cyclophilins and
is crucial for substrate recognition with its phenyl ring forming
the base of the proline-binding pocket.
An analysis of the 100 ns MD trajectories of the holo
(MMEVD-bound) Cyp40 complex showed a very significant re-
duction in the anti-correlated motions between the cyclophilin
and the TPR domains. A comparison of the correlation matrices
of holo and apo structures (both contoured at Cij values less than
–0.75) is shown in Figure 8. The only anti-correlations remain-
ing at this level are between regions 2 and 4. The communication
between the helices of the TPR domain and the active site has
been significantly reduced. The loss of enzyme activity measured
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Figure 6 The temperature dependence of the affinity of Hsp90 peptide for Cyp40
(A) The affinity of Hsp90 peptide for hCyp40 as a function of temperature. (B) Thermodynamic profile of peptide binding
between 10 ◦C and 30 ◦C.
Figure 7 Cyp40 B-factors from apo and holo MD simulations and
X-ray
Average B-factors are greater for the apo form of the protein for both
the cyclophilin and the TPR domains. There is a significant reduction
fluctuation in both the TPR and the cyclophilin domains when MEEVD is
bound. Phe133 forms the base of the active site.
on peptide binding may therefore be related to the dampened mo-
tions within the catalytic domain and the reduced anti-correlated
movements induced by the remote binding of the MEEEVD
peptide.
A further analysis of the holo and apo trajectories identifies an
interesting distortion of the active site binding cleft in the cyclo-
philin domain when the remote TPR domain binds the MEEVD
peptide. The key residues in contact distance with the cyclo-
philin substrate (or CsA inhibitor) lie on either side of a binding
cleft (Figure 9). The pairwise distances between the Cα atoms of
juxtaposed residues on the cleft were monitored and plotted as
distance distributions over the course of the 100 ns trajectories.
The effect of MEEVD binding to the TPR domain is to increase
the distance between Phe80 and His141 (and R75-L42) at one end
of the cleft while closing the gap between Gly92 and Ala123 at the
other end. The distance between the middle residues (Gln83 and
His146) remains constant. These changes are consistent with a
scissor-like motion (Figure 9) that distorts the shape of the bind-
ing cleft and may explain the loss of enzyme activity as being
due to poorer binding of the substrate.
DISCUSSION
Previous studies on TPR domains have proposed that plasticity
in the TPR domain enable it to adopt a range of conformations
with different protein partners [40,41]. The TPR domain of pro-
tein phosphatase-5 (PP5) is significantly unfolded at physiolo-
gical temperatures and binding the –MEEVD C-terminal motif
of Hsp90 is thought to be coupled to folding [41]. Using biophys-
ical methods, we have shown that flexibility in the TPR domain
of Cyp40 is significantly influenced by temperature and that by
forming a complex with –MEEVD peptides the TPR domain of
Cyp40 is stabilized. These experimental results were consistent
with the MD simulations of the apo and holo Cyp40 structures
which showed that binding of the MEEVD peptide to the TPR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8 c© 2015 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution License 3.0
Cyp40 is a temperature sensitive isomerase
Figure 8 Anti-correlated motions of Apo and Holo Cyp40
(A) Anti-correlated motions in Cyp40. MD simulations show clear anti-correlated motions in apo Cyp40 between the
cyclophilin and TPR domains (red; regions 1–6). Anti-correlated motions are much reduced on binding to –MEEVD (black;
regions 2, 4 and 6). The axes of the cross-correlation matrix graph represent amino acids from the N-terminus. (B) Regions
showing anti-correlations have been mapped to the structure of Cyp40. (C) Specific amino acids for each anti-correlated
region.
domain clearly reduces the B-factor for both TPR and cyclophilin
domains.
The allosteric effect of peptide binding to reduce PPIase activ-
ity of Cyp40 Isomerases by ∼30 % was unexpected, but can now
be rationalized in terms of protein dynamics. The PPIase mech-
anism of CypA has been well studied and there is good evidence
for a coupling between dynamics and substrate turn-over. NMR
relaxation experiments have established that millisecond motions
within the PPIase domain of CypA during catalysis occur with a
frequency comparable to substrate turnover [5,42–44]. MD simu-
lations have also predicted that there is a coupling between protein
dynamics and catalysis [6,45–47]. Extensive mutational studies
show it is possible to change the isomerase activity and protein
dynamics of CypA by [42], mutating a residue remote from the
active site [44,48]. The MD results provided in the present paper
suggest an allosteric mechanism in which correlated motion of
the TPR domain is required for optimum PPIase turnover through
communication between active-site residues on the front face of
the β-barrel of Cyp40 that is the supporting template for the
active site residues. This communication between the TPR and
PPIase domains is dampened by binding to the Hsp90 peptide.
The change in shape of the active-site cleft with the scissor-like
motion of the substrate-binding residues serves to pinch together
at the ‘Abu pocket’ end of the cleft and provides a likely explan-
ation for the poorer substrate binding and enzyme activity. The
‘Abu pocket’ binds to the amino acid Abu in CsA.
The measured dissociation constants between Cyp40 and
Hsp90 are relatively weak; for full length Hsp90 at 20 ◦C, the Kd
is 2.9 μM (Kd for MEEVD is 10.7 μM; Supplementary Figure
S2). This suggests that the biological function may require ready
dissociation of the Cyp40–Hsp90 complex. The strong temper-
ature dependence of the interaction between Hsp90 and Cyp40
described in the present study is in the physiological temperature
range. Upon heat shock, the affinity of Cyp40 for MEEVD is sig-
nificantly reduced and equilibrium between bound and unbound
Cyp40 is shifted towards the more enzymatically-active unbound
form of the enzyme. A reasonable hypothesis is that enhanced
isomerase activity may be able to rescue partially folded pro-
teins from unfavourable interactions under conditions of heat or
possibly other stress conditions.
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Figure 9 Binding –MEEVD allosterically alters motions in the active site
The pair-wise distances between key residues in contact distance with the cyclophilin substrate (or CsA inhibitor) lie on
either side of a binding cleft change when MEEVD binds to the TPR domain. CsA is modelled in the active site (1CWA.pdb;
black sticks).
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